Login / Signup

Characterisation of ciclesonide metabolism in human placentae across gestation.

Ashley S MeakinKathryn L GatfordYu-Chin LienMichael D WieseRebecca A SimmonsJanna L Morrison
Published in: Placenta (2024)
Conversion of CIC to des-CIC by the human placenta may preclude its use as a novel GR-agonist in threatened preterm birth. In vivo studies are required to confirm the extent to which placental activation occurs after maternal treatment.
Keyphrases
  • preterm birth
  • endothelial cells
  • gestational age
  • induced pluripotent stem cells
  • birth weight
  • preterm infants
  • body mass index
  • replacement therapy